PanTher Therapeutics Announces Appointment of John Edwards as Executive Chair of the Board of Directors
World’s Largest Medtech Accelerator Announces 61 Startups for its 2023 Cohort
Women Who Lead in Life Sciences Series features Laura Indolfi
PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment
PanTher Therapeutics Doses First Two Patients in Phase 1 Trial of PTM-101 for Treatment of Pancreatic Cancer
